Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Connie W Batlevi, MD,PhD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre Hospitalier de Perpignan
Perpignan, Pyrénées-Orientales, France
- Hospital Universitario de Donostia
Donostia / San Sebastian, Guipúzcoa, Spain
- Hospital Universitario Vall D'Hebrón
Barcelona, Spain
- Hospital del Mar
Barcelona, Spain
- C.H. Regional Reina Sofia
Córdoba, Spain
- Hospital Universitario Infanta Leonor
Madrid, Spain
- Advocate Medical Group - Park Ridge, Luther Lane - Oncology
Park Ridge, Illinois, United States
- Norton Cancer Institute - St. Matthews Campus
Louisville, Kentucky, United States
- Clinical Research Alliance Inc
Lake Success, New York, United States
- Manhattan Hematology Oncology Center
New York, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Bone Marrow Transplant Hematology Oncology Associates
Pittsburgh, Pennsylvania, United States
- Arlington Cancer Center
Arlington, Texas, United States
- Central Texas Veterans Health Care System - Navref
Temple, Texas, United States
- Vista Oncology Inc. Ps
Olympia, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Aug 2018
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2029
- Last update posted
- 10 Apr 2025
- Registered enrollment
- 139
- Registry id
- NCT03600441
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.